<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>111848901366</udiDi>
    <basicUdiDi>4008455339101UB</basicUdiDi>
    <tradeName>Bullrich Heilerde Kapseln</tradeName>
    <deviceName>Bullrich Heilerde Kapseln</deviceName>
    <manufacturerName>delta pronatura GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000020877</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>339</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T13:49:40.206Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436593831271</udiDi>
    <basicUdiDi>843659383XIA623N6</basicUdiDi>
    <tradeName>Direxol</tradeName>
    <deviceName>XILAPLUS AF capsules</deviceName>
    <manufacturerName>Noventure S.L.U.</manufacturerName>
    <manufacturerSrn>ES-MF-000000797</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1313112</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:33:39.960Z</lastUpdated>
  </row>
  <row>
    <udiDi>08428076010365</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Gavidigest Gases e hinchazon</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E03</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:25:57.763Z</lastUpdated>
  </row>
  <row>
    <udiDi>08428076009208</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Gavidigest Gases e hinchazon</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E030</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:25:55.261Z</lastUpdated>
  </row>
  <row>
    <udiDi>08428076009192</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gavidigest Estrenimiento</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E030</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:25:49.290Z</lastUpdated>
  </row>
  <row>
    <udiDi>08056300620464</udiDi>
    <basicUdiDi>B-08056300620464</basicUdiDi>
    <tradeName>Biochetasi Reflusso 2 stick pack IT</tradeName>
    <deviceName>Alfagerd stick pack</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTP057</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:09:11.389Z</lastUpdated>
  </row>
  <row>
    <udiDi>08056300620457</udiDi>
    <basicUdiDi>B-08056300620457</basicUdiDi>
    <tradeName>Biochetasi Reflusso 20 stick pack IT</tradeName>
    <deviceName>Alfagerd stick pack</deviceName>
    <manufacturerName>Labomar S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000007965</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTP057</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:09:10.188Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055719118494</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Gaviscon Intestino Gonfiore e meteorismo</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E003</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:07:04.147Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055719116322</udiDi>
    <basicUdiDi>7649993626FT42306VN</basicUdiDi>
    <tradeName>Gaviscon Intestino Gonfiore e meteorismo</tradeName>
    <deviceName>Sectacol</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C12B02E030</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:05:10.390Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055719116292</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gaviscon Intestino Stitichezza</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E030</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T12:05:09.262Z</lastUpdated>
  </row>
  <row>
    <udiDi>08050624486546</udiDi>
    <basicUdiDi>7649993626FT42307VQ</basicUdiDi>
    <tradeName>Gaviscon Intestino Stitichezza</tradeName>
    <deviceName>Gelselax</deviceName>
    <manufacturerName>DEVINTEC SAGL</manufacturerName>
    <manufacturerSrn>CH-MF-000020271</manufacturerSrn>
    <authorisedRepresentativeName>DEVINTEC HEALTH S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000020256</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>C20B02E008</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:02:16.076Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472039693</udiDi>
    <basicUdiDi>8032472LENOby232</basicUdiDi>
    <tradeName>Lenodiar Pediatric</tradeName>
    <deviceName>Antidiarroico pediatric</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472039693</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:30:56.989Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472038726</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472038726</reference>
    <placedOnMarketCountry>Lithuania</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:30:55.787Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472036531</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472036531</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:30:49.784Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472036395</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472036395</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:30:48.654Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472035817</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472035817</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:30:47.382Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472035794</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472035794</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:30:46.199Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472035787</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472035787</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:30:40.188Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472035770</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472035770</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:30:38.977Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032472035763</udiDi>
    <basicUdiDi>8032472BIOANAby2AA</basicUdiDi>
    <tradeName>Neobianacid pediatric</tradeName>
    <deviceName>Neobianacid</deviceName>
    <manufacturerName>ABOCA S.P.A. SOCIETÀ AGRICOLA</manufacturerName>
    <manufacturerSrn>IT-MF-000029499</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>G0401</emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08032472035763</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-06-30T10:30:37.776Z</lastUpdated>
  </row>
</eudamedExport>